| Old Articles: <Older 2401-2410 Newer> |
|---|
 |
The Motley Fool
June 21, 2004
Seth Jayson |
Wal-Mart Retreats, Charges The latest news from the biggest retailer includes a so-so sales report and reconciliation with MasterCard.   |
The Motley Fool
June 21, 2004
Charly Travers |
Biotech's Full Monte When it comes to valuing biotech companies, the Monte Carlo simulation lets investors leave the guesswork behind and the random sampling to a computer. |
The Motley Fool
June 21, 2004
Brian Gorman |
Clinical Trials Controversy The American Medical Association wants more transparency in clinical trials, a proposal that may leave drug companies and investors with mixed feelings. |
The Motley Fool
June 21, 2004
Alyce Lomax |
Ask Jeeves Focuses The search engine concern shows even more strength in search. |
The Motley Fool
June 21, 2004
Seth Jayson |
Walgreen's Fine Follow-Up It's another solid quarter for America's soon-to-be No. 2 drugstore. |
The Motley Fool
June 21, 2004
Ben McClure |
Lost in Translation Setbacks in Japan shouldn't blur Vodafone's rosy prospects. |
The Motley Fool
June 21, 2004
W.D. Crotty |
Love That Taser Taser raises revenue guidance by 50%. |
The Motley Fool
June 21, 2004
Dave Marino-Nachison |
Jones Seals Maxwell Deal Nearly three months of negotiating and bickering ended for $11 million. |
The Motley Fool
June 21, 2004
Rich Duprey |
aaiPharma Feels the Pain The maker of painkiller Darvocet restates its earnings for the prior two years. |
BusinessWeek
June 28, 2004
Gene G. Marcial |
Oil's Rise Will Lift Suncor An investment pro is betting on Suncor Energy, which extracts crude from Canada's vast oil-sands deposits in Alberta. |
| <Older 2401-2410 Newer> Return to current articles. |
